March 2017 FDA Recall Drug by Teva Pharmaceuticals Usa
D-0703-2017 - Failed Stability Specifications

This Class III drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on March 28, 2017 for the product Drug. The FDA reported the reason for recall as failed stability specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0703-2017

Reason for Recall
Failed Stability Specifications
Initiated
03-28-2017
Reported
05-17-2017
Quantity
49,089 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Teva Pharmaceuticals USA
PrednisoLONE Oral Solution USP, 15 mg/5mL, alcohol content: 5%(v/v) 240 mL bottle, Rx Only, Manufactured in Canada By: CONTRACT PHARMACEUTICALS LIMITED CANADA, Ontario, Canada, L5N 6L6, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-6118-87

Batch or Lot Expiration Information

Lot# 94358; Exp. 05/17
Lot# 94920A; Exp. 07/17
Lot# 97083A; Exp. 12/17